)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Venture Life Group
Venture Life Group (VLG) investor relations material
Venture Life Group Transition period summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Transition period summary1 Oct, 2026
Executive summary
Focused pure-play consumer healthcare business after divesting CDMO/manufacturing and Oral Care operations; portfolio spans four categories and eight brands.
Revenue grew 16% like-for-like over the 17 months to May 2026, with momentum concentrated in Power Brands; distribution points increased 40% across UK and US channels.
Acquired FemiClear and CUROXEN on June 2, 2026, establishing US operations and adding a sales team and cross-selling platform.
Danny Wells is due to succeed Jerry Randall as CEO on January 1, 2027; strategy remains focused on organic growth, US expansion and selective M&A.
Financial highlights
Revenue was £50m for the 17 months to May 2026, up 16% like-for-like; gross profit was £22.3m versus £12.2m for 2024.
EBITDA was £7.9m for the 17-month period, including £7.1m LTM to May 2026, up 19% underlying; adjusted EBITDA was £7.9m LTM.
Adjusted diluted EPS increased to 5.8p from 3.1p in 2024.
Free cash flow was £3.5m, affected by exceptional transformation costs; operating cash conversion was 56.2% and FCF conversion 44.7%.
Profit before tax was £3.4m; closing cash was £11.5m, versus £18.8m net debt at end-2024.
Outlook and guidance
FY26/27 revenue guidance is £54.7m and EBITDA guidance is £11.6m; revenue components include £39m core LTM revenue, ~£11m from FemiClear and £4m organic growth.
Expected FCF is £7.5m–£8m for the 12 months to May 2027; management also cited £8m cash generation in the current financial period.
FemiClear revenue is expected to reach £17m by 2029, with high-£3m to £4m EBITDA, cash conversion above 90% and ~20% annual revenue growth.
Medium-term sustainable organic growth is modeled at ~15%; adjusted EBITDA margins are expected to reach the low 20s relatively soon, with 25% as a longer-term target.
Long-term ambition is £300m+ revenue and a 25% EBITDA margin by 2030, supported by organic growth and acquisitions; management said no equity raise is required.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Venture Life Group
- Revenue up 30.9% to £50m, with Power Brands and US acquisition fueling growth.VLG
Trading update - Revenue up 32.2% to £35.2m, strong cash and Power Brands drive future M&A and growth.VLGH2 2025
- 32% revenue growth and strong UK brand performance drive confidence in future targets.VLGH2 2025 TU
- Revenue up 43.1%, gross margin at 43.1%, and net cash £34.1m after strategic divestments.VLGH1 2025
- Divestment completed, revenues up 38%, and new leadership drives brand-focused growth.VLGTrading Update
- Strategic pivot to high-margin brands and digital growth, driven by divestments and Health & Her deal.VLGH2 2024
- 17% brand growth, margin gains, and strong cash flow with further expansion expected.VLGH1 2024
- Strong UK brand growth and improved margins position VLG for full-year performance in line with expectations.VLGH1 2024 Trading Update
- €62m divestment streamlines focus on high-margin healthcare, funding growth and M&A.VLGInvestor Update
Venture Life Group
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Venture Life Group PLC is a UK-based consumer healthcare company engaged in the development, manufacture, and distribution of self-care products. The company's portfolio includes oral care, dermatology, and women's health products, which are sold under its own brands as well as through distribution and licensing partnerships. Venture Life operates manufacturing facilities and serves both domestic and international markets through retail, pharmacy, and e-commerce channels. The company is headquartered in Bracknell, United Kingdom, and its shares are listed on the AIM.